TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Pfizer Anti-Infectives AB
Closing information (x1000 SEK)
| Closing information | 2023/11 | 2022/11 | 2021/11 |
| Turnover |
2,115,306
|
1,353,259
|
330,523 |
| Financial expenses |
0
|
472
|
1,267 |
| Earnings before taxes |
1,010,662
|
415,181
|
-567,244 |
| EBITDA |
1,042,889
|
474,848
|
-506,783 |
| Total assets |
2,513,576
|
1,580,650
|
1,142,755 |
| Current assets |
66,595
|
112,359
|
217,691 |
| Current liabilities |
756,144
|
625,691
|
517,428 |
| Equity capital |
1,757,432
|
954,959
|
625,327 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2023/11 | 2022/11 | 2021/11 |
| Solvency |
69.9%
|
60.4%
|
54.7% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
47.8%
|
30.7%
|
-171.6% |
| Return on assets (ROA) |
40.2%
|
26.3%
|
-49.5% |
| Current ratio |
8.8%
|
18.0%
|
42.1% |
| Return on equity (ROE) |
57.5%
|
43.5%
|
-90.7% |
| Change turnover |
762,047
|
1,022,736
|
-1,197,824 |
| Change turnover % |
56%
|
309%
|
-78% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/11 | 2022/11 | 2021/11 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.